Clinical trial
The Influence of FP-10 on the Eradication Rates of H. Pylori by a Triple Therapy
NCT00281047 · Hamamatsu University, Other · Unknown status
Key facts
| NCT number | NCT00281047 |
|---|---|
| Title | The Influence of FP-10 on the Eradication Rates of H. Pylori by a Triple Therapy |
| Official title | The Phase 2 Study of FP-10, the Food Ingredient Derived From Milk Casein, on the Eradication Rates of Helicobacter Pylori by a Triple Therapy With Lansoprazole, Amoxicillin, and Clarithromycin |
| Lead sponsor | Hamamatsu University, Other |
| Collaborators | Oita University |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Helicobacter Pylori |
| Intervention type | Drug |
| Interventions | FP-10 |
| Enrollment | 138 |
| Start date | Jan 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Jan 24, 2006 |
| Last update posted | Jan 27, 2006 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: